Madrigal Pharmaceuticals (MDGL) Return on Sales Growth (3y) (2013)

Madrigal Pharmaceuticals (MDGL) Return on Sales Growth (3y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -76.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 8.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.00
10 Madrigal Pharmaceuticals 14.79 Bn 13.95 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 -589.00
Sep 30, 2013 -857.00
Jun 30, 2013 -622.00